Primary peritoneal serous papillary carcinoma: A new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer

被引:56
作者
Halperin, R [1 ]
Zehavi, S
Langer, R
Hadas, E
Bukovsky, I
Schneider, D
机构
[1] Assaf Harofe Med Ctr, Dept Obstet & Gynecol, IL-70300 Zerifin, Israel
[2] Peptor Labs, Ness Ziona, Israel
[3] Assaf Harofe Med Ctr, Dept Pathol, IL-70300 Zerifin, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
BRCA mutations; epidemiologic trend; ovarian serous papillary cancer; primary peritoneal serous papillary carcinoma;
D O I
10.1046/j.1525-1438.2001.01027.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the study was to examine the prevalence of primary peritoneal serous papillary carcinoma (PPSPC) as compared with ovarian serous papillary cancer (OSPC), and to study the clinicopathologic features and the frequency of germline BRCA(1) and BRCA(2) mutations in patients with PPSPC compared with those with OSPC. The study group included 28 cases of PPSPC. The comparison group included 35 female patients with OSPC, matched for stage, grade, and histologic subtype. All tumors were staged as either IIIB, IIIC or IV according to FIGO criteria. The patient characteristics, family and personal history of malignancies, the prevalence of germline BRCA mutations, clinicopathologic findings, presenting symptoms, pre- and intraoperative findings, and survival were compared in a matched-case retrospective study comparing patients with PPSPC vs. those with OSPC. Statistical analysis was made using Student's t-test, Chi-square, Wilcoxon, Kaplan-Meier and log-rank methods. Women with PPSPC had a significantly earlier menarche (P=0.037) and a higher number or births (P=0.03) than women with OSPC. No difference was found with regard to the prevalence of germline BRCA mutations in women with PPSPC compared with women with OSPC (7.1% vs. 25.7%). There was a significant increase (P=0.02) in the incidence of abdominal distension as reported by PPSPC (64%) vs. OSPC patients (26%). Significantly more women with PPSPC than with OSPC presented with clinical ascites (P=0.0001) and without palpable pelvic mass (P=0.000001). On exploratory laparotomy, significantly more women with PPSPC than with OSPC had a minimal disease in the pelvis (P=0.0087). Three-year survival analysis demonstrated a significantly worse survival rate for the PPSPC group than for the OSPC group (P=0.017). A significant increase in the prevalence of PPSPC compared with OSPC was observed during the study years (P=0.00001). We concluded that PPSPC and OSPC might be two distinct cancers, presenting a new epidemiologic trend regarding the increased incidence of PPSPC.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 31 条
[11]  
GOONERATNE S, 1981, INT J GYNECOL PATHOL, V1, P241
[12]   Peritoneal fluid gonadotropins and ovarian hormones in patients with ovarian cancer [J].
Halperin, R ;
Hadas, E ;
Langer, R ;
Bukovsky, I ;
Schneider, D .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (06) :502-507
[13]   CLONAL ORIGIN OF EPITHELIAL OVARIAN-CARCINOMA - ANALYSIS BY LOSS OF HETEROZYGOSITY, P53-MUTATION, AND X-CHROMOSOME INACTIVATION [J].
JACOBS, IJ ;
KOHLER, MF ;
WISEMAN, RW ;
MARKS, JR ;
WHITAKER, R ;
KERNS, BAJ ;
HUMPHREY, P ;
BERCHUCK, A ;
PONDER, BAJ ;
BAST, RC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (23) :1793-1798
[14]   Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: Implications for ovarian cancer screening [J].
Karlan, BY ;
Baldwin, RL ;
Lopez-Luevanos, E ;
Raffel, LJ ;
Barbuto, D ;
Narod, S ;
Platt, LD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (04) :917-925
[15]   PAPILLARY SEROUS CARCINOMA OF THE PERITONEAL SURFACE - MATCHED-CASE COMPARISON WITH PAPILLARY SEROUS OVARIAN-CARCINOMA [J].
KILLACKEY, MA ;
DAVIS, AR .
GYNECOLOGIC ONCOLOGY, 1993, 51 (02) :171-174
[16]  
Kowalski LD, 1997, CANCER, V79, P1587, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1587::AID-CNCR22>3.0.CO
[17]  
2-T
[18]   PERITONEAL PAPILLARY CARCINOMA [J].
LELE, SB ;
PIVER, MS ;
MATHARU, J ;
TSUKADA, Y .
GYNECOLOGIC ONCOLOGY, 1988, 31 (02) :315-320
[19]   ADVANCED OVARIAN-CARCINOMA - MOLECULAR EVIDENCE OF UNIFOCAL ORIGIN [J].
LI, SB ;
HAN, H ;
RESNIK, E ;
CARCANGIU, ML ;
SCHWARTZ, PE ;
YANGFENG, TL .
GYNECOLOGIC ONCOLOGY, 1993, 51 (01) :21-25
[20]   SEROUS SURFACE PAPILLARY CARCINOMA - A CLINICOPATHOLOGIC STUDY OF 10 CASES AND COMPARISON WITH STAGE-III-STAGE-IV OVARIAN SEROUS CARCINOMA [J].
MILLS, SE ;
ANDERSEN, WA ;
FECHNER, RE ;
AUSTIN, MB .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1988, 12 (11) :827-834